ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$5.5700
+0.0200 ( +0.36% ) 0.0K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$5.5700

Previous close


$5.5500

Volume


0.0K

Market cap


$3.96M

Day range


$5.5060 - $5.5500

52 week range


$4.6000 - $34.2200

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Apr 10, 2024
8-k 8K-related 15 Apr 10, 2024
8-k 8K-related 15 Apr 04, 2024
10-k Annual reports 88 Apr 01, 2024
8-k 8K-related 14 Feb 26, 2024
def Proxies and info statements 6 Jan 24, 2024
8-k 8K-related 13 Jan 18, 2024
3 Insider transactions 1 Jan 16, 2024
pre Proxies and info statements 4 Jan 05, 2024
8-k 8K-related 15 Nov 29, 2023

Latest News